Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Non-Current Deffered Revenue (2022 - 2024)

SBC Medical Group Holdings filings provide 3 years of Non-Current Deffered Revenue readings, the most recent being $4.0 million for Q2 2024.

  • On a quarterly basis, Non-Current Deffered Revenue changed 0.0% to $4.0 million in Q2 2024 year-over-year; TTM through Jun 2024 was $4.0 million, a 0.0% change, with the full-year FY2023 number at $4.0 million, changed 0.0% from a year prior.
  • Non-Current Deffered Revenue hit $4.0 million in Q2 2024 for SBC Medical Group Holdings, roughly flat from $4.0 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $4.0 million in Q4 2022 to a low of $4.0 million in Q4 2022.
  • Median Non-Current Deffered Revenue over the past 3 years was $4.0 million (2022), compared with a mean of $4.0 million.
  • The widest YoY moves for Non-Current Deffered Revenue: up 0.0% in 2023, down 0.0% in 2023.
  • SBC Medical Group Holdings' Non-Current Deffered Revenue stood at $4.0 million in 2022, then changed by 0.0% to $4.0 million in 2023, then changed by 0.0% to $4.0 million in 2024.
  • The last three reported values for Non-Current Deffered Revenue were $4.0 million (Q2 2024), $4.0 million (Q1 2024), and $4.0 million (Q4 2023) per Business Quant data.